- Home
- ORIC vs ATRO Comparison
ORIC vs ATRO Comparison
Compare ORIC & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORIC | ATRO |
|---|---|---|
| Founded | 2014 | 1968 |
| Country | United States | United States |
| Employees | N/A | 2620 |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 2.7B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ORIC | ATRO |
|---|---|---|
| Price | $10.83 | $63.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 2 |
| Target Price | $20.00 | ★ $86.00 |
| AVG Volume (30 Days) | ★ 1.4M | 625.1K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $14.92 |
| Revenue Next Year | N/A | $8.81 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.90 | $19.90 |
| 52 Week High | $14.93 | $83.96 |
Technical Indicators
Market Signals| Indicator | ORIC | ATRO |
|---|---|---|
| Relative Strength Index (RSI) | 41.27 | 35.03 |
| Support Level | $9.88 | $51.55 |
| Resistance Level | $12.12 | $82.37 |
| Average True Range (ATR) | 0.82 | 4.14 |
| MACD | -0.31 | -1.21 |
| Stochastic Oscillator | 6.87 | 4.67 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.